PODDINSULET CORP

Nasdaq insulet.com


$ 176.38 $ 0.81 (0.46 %)    

Thursday, 09-May-2024 11:41:17 EDT
QQQ $ 440.99 $ 0.53 (0.12 %)
DIA $ 392.51 $ 2.40 (0.62 %)
SPY $ 518.87 $ 1.43 (0.28 %)
TLT $ 90.16 $ 0.12 (0.13 %)
GLD $ 215.83 $ 1.13 (0.53 %)
$ 175.57
$ 177.20
$ 0.00 x 0
$ 176.53 x 100
$ 175.94 - $ 178.35
$ 125.82 - $ 331.65
1,071,807
na
12.93B
$ 1.11
$ 62.66
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-23-2024 12-31-2023 10-K
2 11-02-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-05-2023 03-31-2023 10-Q
5 02-24-2023 12-31-2022 10-K
6 11-04-2022 09-30-2022 10-Q
7 08-04-2022 06-30-2022 10-Q
8 05-05-2022 03-31-2022 10-Q
9 02-23-2022 12-31-2021 10-K
10 11-04-2021 09-30-2021 10-Q
11 08-05-2021 06-30-2021 10-Q
12 05-07-2021 03-31-2021 10-Q
13 02-24-2021 12-31-2020 10-K
14 11-05-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-08-2020 03-31-2020 10-Q
17 02-26-2020 12-31-2019 10-K
18 11-06-2019 09-30-2019 10-Q
19 08-06-2019 06-30-2019 10-Q
20 05-03-2019 03-31-2019 10-Q
21 02-26-2019 12-31-2018 10-K
22 11-02-2018 09-30-2018 10-Q
23 08-02-2018 06-30-2018 10-Q
24 05-04-2018 03-31-2018 10-Q
25 02-22-2018 12-31-2017 10-K
26 11-03-2017 09-30-2017 10-Q
27 08-04-2017 06-30-2017 10-Q
28 05-09-2017 03-31-2017 10-Q
29 02-28-2017 12-31-2016 10-K
30 11-04-2016 09-30-2016 10-Q
31 08-04-2016 06-30-2016 10-Q
32 04-29-2016 03-31-2016 10-Q
33 02-29-2016 12-31-2015 10-K
34 11-06-2015 09-30-2015 10-Q
35 08-12-2015 06-30-2015 10-Q
36 04-30-2015 03-31-2015 10-Q
37 02-26-2015 12-31-2014 10-K
38 11-05-2014 09-30-2014 10-Q
39 08-07-2014 06-30-2014 10-Q
40 05-07-2014 03-31-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 wolfe-research-upgrades-insulet-to-outperform-announces-200-price-target

Wolfe Research analyst Mike Polark upgrades Insulet (NASDAQ:PODD) from Peer Perform to Outperform and announces $200 price t...

 top-stocks-not-named-nvidia-you-need-to-know-about-in-2024-heres-what-investors-think-about-them-wall-street-vs-reddit

Nvidia Corp. is one of the leading top stocks with 60% gain in 2024, but other lesser-known names have outperformed.

 on-thursday-february-22-insulet-gave-q1-2024-revenue-growth-guidance-of-17-20-for-fy24-the-company-expects-revenue-growth-in-the-range-of-12-17

2024 Outlook:Revenue Guidance (in constant currency):Guidance for the first quarter and full year 2024 reflects an estimated $2...

 surgery-partners-posts-weak-sales-joins-kosmos-energy-moderna-and-other-big-stocks-moving-lower-on-monday

U.S. stocks were slightly higher, with the Nasdaq Composite gaining around 10 points on Monday. Shares of Surgery Partners, I...

 barclays-maintains-equal-weight-on-insulet-lowers-price-target-to-213

Barclays analyst Matt Miksic maintains Insulet (NASDAQ:PODD) with a Equal-Weight and lowers the price target from $214 to $213.

 jp-morgan-maintains-overweight-on-insulet-raises-price-target-to-225

JP Morgan analyst Robbie Marcus maintains Insulet (NASDAQ:PODD) with a Overweight and raises the price target from $190 to $...

 nasdaq-sp-500-set-for-mixed-open-after-nvidia-euphoria-analyst-picks-major-market-catalyst-this-year-if-there-are-no-rate-cuts

After the exuberance seen on Thursday, investors may assess whether it was an irrational one, and futures trading on Friday ref...

 insulet-q4-earnings-insights
Insulet: Q4 Earnings Insights
02/22/2024 21:15:26

 insulet-q4-2023-adj-eps-140-beats-066-estimate-sales-50980m-beat-46105m-estimate

Insulet (NASDAQ:PODD) reported quarterly earnings of $1.40 per share which beat the analyst consensus estimate of $0.66 by 112....

 nasdaq-sp-500-futures-jump-as-nvidia-surge-raises-fomo-rally-hopes-analyst-tells-why-jobs-data-holds-key-for-momentum

Market participants remain attentive to several factors shaping the day's trading landscape, including scheduled Fed speech...

 earnings-scheduled-for-february-22-2024

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is likely to report quarterly earnings at $0.28 per share on reve...

 stifel-maintains-hold-on-insulet-raises-price-target-to-208

Stifel analyst Mathew Blackman maintains Insulet (NASDAQ:PODD) with a Hold and raises the price target from $163 to $208.

 amazoncom-to-rally-over-38-here-are-10-top-analyst-forecasts-for-thursday

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION